⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ANVS News
Annovis Bio, Inc.
Annovis Achieves Significant Milestones and Sustains Strong Progress in Phase 3 Alzheimer’s Program
globenewswire.com
ANVS
Annovis Announces $3.4 Million Registered Direct Offering of Common Stock Priced At-the-Market under the NYSE Rules
globenewswire.com
ANVS
Annovis Announces Closing of $6 Million Registered Direct Offering of Common Stock
globenewswire.com
ANVS
Annovis Announces $6 Million Registered Direct Offering of Common Stock
globenewswire.com
ANVS
Annovis Announces Novel Biomarker Data in Alzheimer’s Patients Supporting Buntanetap’s Potential as a Disease-Modifying Treatment
globenewswire.com
ANVS
Annovis Appoints Mark Guerin as Chief Financial Officer
globenewswire.com
ANVS